Acta Med. 2002, 45: 107-110
https://doi.org/10.14712/18059694.2019.64
Effect of Atropine and the Oxime HI-6 on Low-Level Sarin-Induced Alteration of Performance of Rats in a T-Maze
References
1. Afifi AA, Azen SP. Statistical analysis and computer oriented approach. 2nd ed. New York: Academic Press, 1979:442–5.
2. JJ, Heithold DL, Chon SH. Long-term behavioral and learning abnormalities produced by the irreversible cholinesterase inhibitor soman: effect of a standard pretreatment regimen and clonidine. Toxicol Lett 1990; 52:319–29.
<https://doi.org/10.1016/0378-4274(90)90042-K>
3. PJ, Padilla SS, Ward T, Pope CN, Olszyk VB. Behavioral and neurochemical changes in rats dosed repeatedly with diisopropylfluorophosphate. J Pharmacol Exp Ther 1991; 256:741–50.
4. JC, Hoskins BH, Ho IK. A striatal serotonergic involment of the behavioural affects of anticholinesterase organophosphates. Eur J Pharmacol 1984; 98:129–32.
<https://doi.org/10.1016/0014-2999(84)90118-3>
5. DJ, Daniels SE, Henderson C, Eglen RM, Wong EHF. Ondansetron improves cognitive performance in the Morris water maze spatial navigation task. Psychopharmacology 1995; 120(4):409–17.
<https://doi.org/10.1007/BF02245812>
6. EM, Hartmann RJ, Leal BZ, Geller I. Neurobehavioral effects of repeated subletal soman in primates. Pharmacol Biochem Behav 1985; 23:1003–12.
<https://doi.org/10.1016/0091-3057(85)90107-8>
7. J. Comparison of efficacy of two oximes (HI-6 and obidoxime) in soman poisoning in rats. Toxicology 1995; 101:67–74.
<https://doi.org/10.1016/0300-483X(95)03091-S>
8. J, Koupilová M. Neuroprotective effects of currently used antidotes in soman- poisoned rats. Pharmacol Biochem Behav 2000; 67:663–8.
<https://doi.org/10.1016/S0091-3057(00)00410-X>
9. J, Koupilová M, Vachek J. Long term effects of low-level sarin inhalation exposure on the spatial memory of rats in a T-maze. Acta Med (Hradec Králové) 2001; 44(3):93–6.
10. A. REM sleep pathway and anticholinesterase intoxication: a mechanism for nerve agent-induced, central respiratory failure. Med Hypotheses 1993; 41:141–9.
<https://doi.org/10.1016/0306-9877(93)90061-T>
11. M, Herink J. Effects of mescaline and its derivate N-(3,4,5-trimethoxyethyl)- aziridine on the spatial orientation of rats in T-maze. Physiol Bohem 1989; 38:497–502.
12. M, Herink J. An attempt to antagonize DSP-4 induced impairment of the performance of rats in a T-maze. Homeostasis 1995; 36:41–2.
13. M, Vachek J, Fusek J, Patočka J, Herink J. Neurotoxic effects of soman in animal experimental poisoning and the influence of therapy. Homeostasis 1996; 37:266.
14. G, Carpantier P, Sentenac-Roumanou H, Morelis P. Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol 1983; 61:123–9.
<https://doi.org/10.1007/BF00697391>
15. TC. Organophosphate poisoning. Pharmacol Ther 1993; 58:51–66.
<https://doi.org/10.1016/0163-7258(93)90066-M>
16. DM, Lenz DE, Groff WA, Kaminskis A, Froehlich HL. The effect of blood flow and detoxication on in vivo cholinesterase inhibition by soman in rats. Toxicol Appl Pharmacol 1987; 88:66–76.
<https://doi.org/10.1016/0041-008X(87)90270-5>
17. BE, Costa LG, Murphy SD. Spatial memory impairment and central muscarinic receptor loss following prolonged treatment with organophosphates. Toxicol Lett 1988; 40:47–56.
<https://doi.org/10.1016/0378-4274(88)90182-8>
18. CG, Singer AW, Harrington DG. Acute neuropathology in soman poisoned rats. Neurotoxicology 1982; 297:681–3.
19. JM. Soman neurotoxicity. Fundam Appl Toxicol 1981; 1:242–9.
<https://doi.org/10.1016/S0272-0590(81)80065-6>
20. K, Olton D, Annau Z. Repeated exposure to diisopropylfluorophosphate (DFP) produces increased sensitivity to cholinergic antagonists in discrimination retention and reversal. Psychopharmacology (Berlin) 1990; 100:267–74.
<https://doi.org/10.1007/BF02244417>
21. Taylor P. Anticholinesterase agents. In: Hardman JG, Limbird LE (eds): The Pharmacological Basis of Therapeutics, 9th ed. New York: McGraw Hill, 1996: 129.
22. HPM, Busker RW, Melchers BPC, Bruijnzeel PLB. Pharmacological effects of oximes: how relevant are they? Arch Toxicol 1996; 70:779–86.
<https://doi.org/10.1007/s002040050340>
